Clinical Trial Update: Safety & Efffficacy of Genakumab in Patients With Frequent Flares [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of Genakumab in patients with frequent flares of acute gout arthritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Genakumab

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Acute Gout Arthritis | Phase 3 | Status: COMPLETED